Steric accessibility of the HIV-1 gp41 N-trimer region

J Biol Chem. 2005 Apr 1;280(13):12567-72. doi: 10.1074/jbc.M412770200. Epub 2005 Jan 18.

Abstract

During human immunodeficiency virus entry, gp41 undergoes a series of conformational changes that induce membrane fusion. Immediately prior to fusion, gp41 exists in a prehairpin intermediate in which the N- and C-peptide regions of gp41 are exposed. Rearrangement of this intermediate into a six-helix bundle composed of a trimeric coiled coil from the N-peptide region (N-trimer) surrounded by three peptides from the C-peptide region provides the driving force for membrane fusion, whereas prevention of six-helix bundle formation inhibits viral entry. Because of its central role in mediating viral entry, the N-trimer region of gp41 is a key vaccine target. Extensive efforts to discover potent and broadly neutralizing antibodies (Abs) against the N-trimer region have, thus far, been unsuccessful. In this study, we attached a potent C-peptide inhibitor that binds to the N-trimer region to cargo proteins of various sizes to examine the steric accessibility of the N-trimer during fusion. These inhibitors show a progressive loss of potency with increasing cargo size. Extension of the cargo/C-peptide linker partially restores inhibitory potency. These results demonstrate that the human immunodeficiency virus defends its critical hairpin-forming machinery by steric exclusion of large proteins and may explain the current dearth of neutralizing Abs against the N-trimer. In contrast, previous results suggest the C-peptide region is freely accessible during fusion, demonstrating that the N- and C-peptide regions are in structurally distinct environments. Based on these results, we also propose new strategies for the generation of neutralizing Abs that overcome this steric block.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / chemistry
  • Cell Fusion
  • Dimerization
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • HIV Envelope Protein gp41 / chemistry*
  • HIV Envelope Protein gp41 / physiology*
  • Humans
  • Inhibitory Concentration 50
  • Models, Biological
  • Peptides / chemistry
  • Plasmids / metabolism
  • Protein Binding
  • Protein Conformation
  • Protein Structure, Tertiary
  • Proteins / chemistry
  • Stereoisomerism
  • Surface Plasmon Resonance
  • Time Factors
  • Ultraviolet Rays

Substances

  • Antibodies, Monoclonal
  • Enzyme Inhibitors
  • HIV Envelope Protein gp41
  • Peptides
  • Proteins